Of four genotypes of Encephalitozoon cuniculi, E. cuniculi genotype II is considered to represent a parasite that occurs in many host species in a latent asymptomatic form, whereas E. cuniculi genotype III seems to be more aggressive, and infections caused by this strain can lead to the death of even immunocompetent hosts. Although albendazole has been considered suitable for treatment of Encephalitozoon species, its failure in control of E. cuniculi genotype III infection has been reported. This study determined the effect of a 100× recommended daily dose of albendazole on an Encephalitozoon cuniculi genotype III course of infection in immunocompetent and immunodeficient mice and compared the results with those from experiments performed with a lower dose of albendazole and E. cuniculi genotype II. The administration of the regular dose of abendazole during the acute phase of infection reduced the number of affected organs in all strains of mice and absolute counts of spores in screened organs. However, the effect on genotype III was minor. Surprisingly, no substantial effect was recorded after the use of a 100× dose of albendazole, with larger reductions seen only in the number of affected organs and absolute counts of spores in all strains of mice, implying variations in albendazole resistance between these Encephalitozoon cuniculi genotypes. These results imply that differences in the course of infection and the response to treatment depend not only on the immunological status of the host but also on the genotype causing the infection. Understanding how microsporidia survive in hosts despite targeted antimicrosporidial treatment could significantly contribute to research related to human health.

Faculty of Agriculture University of South Bohemia in České Budějovice České Budějovice Czech Republic

Faculty of Science University of South Bohemia in České Budějovice České Budějovice Czech Republic

Institute of Parasitology Biology Centre Czech Academy of Science České Budějovice Czech Republic

Zobrazit více v PubMed

Weber R, Bryan RT, Schwartz DA, Owen RL. 1994. Human microsporidial infections. Clin Microbiol Rev 7:426–461. doi:10.1128/cmr.7.4.426. PubMed DOI PMC

Wright JH, Craighead EM. 1922. Infectious motor paralysis in young rabbits. J Exp Med 36:135–140. doi:10.1084/jem.36.1.135. PubMed DOI PMC

Levaditi C, Nicolau S, Schoen R. 1923. L`agent étiologique de l`encéphalite épizootique du lapin (Encephalitozoon cuniculi). C R Soc Biol Paris 89:984–986.

Shadduck JA. 1969. Nosema cuniculi: in vitro isolation. Science 166:516–517. doi:10.1126/science.166.3904.516. PubMed DOI

Hocevar SN, Paddock CD, Spak CW, Rosenblatt R, Diaz-Luna H, Castillo I, Luna S, Friedman GC, Antony S, Stoddard RA, Tiller RV, Peterson T, Blau DM, Sriram RR, da Silva A, de Almeida M, Benedict T, Goldsmith CS, Zaki SR, Visvesvara GS, Kuehnert MJ, Microsporidia Transplant Transmission Investigation Team. 2014. Microsporidiosis acquired through solid organ transplantation: a public health investigation. Ann Intern Med 160:213–220. doi:10.7326/M13-2226. PubMed DOI PMC

Abu-Akkada SS, El Kerdany ED, Mady RF, Diab RG, Khedr GA, Ashmawy KI, Lotfy WM. 2015. Encephalitozoon cuniculi infection among immunocompromised and immunocompetent humans in Egypt. Iran J Parasitol 10:561–570. PubMed PMC

Kicia M, Wesolowska M, Kopacz Z, Jakuszko K, Sak B, Květonová D, Krajewska M, Kváč M. 2016. Prevalence and molecular characteristics of urinary and intestinal microsporidia infections in renal transplant recipients. Clin Microbiol Infect 22:462.e5–e9. doi:10.1016/j.cmi.2016.01.014. PubMed DOI

Didier ES, Vossbrinck CR, Baker MD, Rogers LB, Bertucci DC, Shadduck JA. 1995. Identification and characterization of three Encephalitozoon cuniculi genotypes. Parasitology 111:411–421. doi:10.1017/S0031182000065914. PubMed DOI

Talabani H, Sarfati C, Pillebout E, van Gool T, Derouin F, Menotti J. 2010. Disseminated infection with a new genovar of Encephalitozoon cuniculi in a renal transplant recipient. J Clin Microbiol 48:2651–2653. doi:10.1128/JCM.02539-09. PubMed DOI PMC

Kotková M, Sak B, Květoňová D, Kváč M. 2013. Latent microsporidiosis caused by Encephalitozoon cuniculi in immunocompetent hosts: a murine model demonstrating the ineffectiveness of the immune system and treatment with albendazole. PLoS One 8:e60941. doi:10.1371/journal.pone.0060941. PubMed DOI PMC

Kotková M, Sak B, Hlásková L, Kváč M. 2017. The course of infection caused by Encephalitozoon cuniculi genotype III in immunocompetent and immunodeficient mice. Exp Parasitol 182:16–21. doi:10.1016/j.exppara.2017.09.022. PubMed DOI

Sak B, Kotková M, Hlásková L, Kváč M. 2017. Limited effect of adaptive immune response to control encephalitozoonosis. Parasite Immunol 39:e12496. doi:10.1111/pim.12496. PubMed DOI

Sak B, Brdíčková K, Holubová N, Květoňová D, Hlásková L, Kváč M. A massive systematic infection of Encephalitozoon cuniculi genotype III in mice does not cause clinical signs. PLoS One, in press. PubMed

Didier ES, Maddry JA, Brindley PJ, Stovall ME, Didier PJ. 2005. Therapeutic strategies for human microsporidia infections. Expert Rev Anti Infect Ther 3:419–434. doi:10.1586/14787210.3.3.419. PubMed DOI

Akiyoshi DE, Weiss LM, Feng X, Williams BA, Keeling PJ, Zhang Q, Tzipori S. 2007. Analysis of the beta-tubulin genes from Enterocytozoon bieneusi isolates from a human and rhesus macaque. J Eukaryot Microbiol 54:38–41. doi:10.1111/j.1550-7408.2006.00140.x. PubMed DOI PMC

Franzen C, Salzberger B. 2008. Analysis of the beta-tubulin gene from Vittaforma corneae suggests benzimidazole resistance. Antimicrob Agents Chemother 52:790–793. doi:10.1128/AAC.00928-07. PubMed DOI PMC

Cruz MC, Edlind T. 1997. β-Tubulin genes and the basis for benzimidazole sensitivity of the opportunistic fungus Cryptococcus neoformans. Microbiology 143:2003–2008. doi:10.1099/00221287-143-6-2003. PubMed DOI

Costa SF, Weiss LM. 2000. Drug treatment of microsporidiosis. Drug Resist Updat 3:384–399. doi:10.1054/drup.2000.0174. PubMed DOI

Gritz DC, Holsclaw DS, Neger RE, Whitcher JP Jr, Margolis TP. 1997. Ocular and sinus microsporidial infection cured with systemic albendazole. Am J Ophthalmol 124:241–243. doi:10.1016/s0002-9394(14)70792-5. PubMed DOI

Katiyar SK, Edlind TD. 1997. In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives. Antimicrob Agents Chemother 41:2729–2732. doi:10.1128/AAC.41.12.2729. PubMed DOI PMC

Johny S, Whitman DW; Bridge Study Group. 2008. Effect of four antimicrobials against an Encephalitozoon sp. (Microsporidia) in a grasshopper host. Parasitol Int 57:362–367. doi:10.1016/j.parint.2008.03.002. PubMed DOI

Weber R, Deplazes P, Flepp M, Mathis A, Baumann R, Sauer B, Kuster H, Lüthy R. 1997. Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N Engl J Med 336:474–478. doi:10.1056/NEJM199702133360704. PubMed DOI

Didier ES. 1997. Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro. Antimicrob Agents Chemother 41:1541–1546. doi:10.1128/AAC.41.7.1541. PubMed DOI PMC

Lallo MA, da Costa LF, de Castro JM. 2013. Effect of three drugs against Encephalitozoon cuniculi infection in immunosuppressed mice. Antimicrob Agents Chemother 57:3067–3071. doi:10.1128/AAC.00157-13. PubMed DOI PMC

Engler H, Zawatzky R, Kirchner H, Armerding D. 1982. Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice. Arch Virol 74:239–247. doi:10.1007/bf01314157. PubMed DOI

Beil WJ, Meinardus-Hager G, Neugebauer DC, Sorg C. 1992. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J Leukoc Biol 52:135–142. doi:10.1002/jlb.52.2.135. PubMed DOI

Chiodini RJ, Buergelt CD. 1993. Susceptibility of BALB/c, C57/B6 and C57/B10 mice to infection with Mycobacterium paratuberculosis. J Comp Pathol 109:309–319. doi:10.1016/S0021-9975(08)80295-2. PubMed DOI

Karp JD, Cohen N, Moynihan JA. 1994. Quantitative differences in interleukin-2 and interleukin-4 production by antigen-stimulated splenocytes from individually- and group-housed mice. Life Sci 55:789–795. doi:10.1016/0024-3205(94)00562-1. PubMed DOI

Fransen F, Zagato E, Mazzini E, Fosso B, Manzari C, El Aidy S, Chiavelli A, D'Erchia AM, Sethi MK, Pabst O, Marzano M, Moretti S, Romani L, Penna G, Pesole G, Rescigno M. 2015. BALB/c and C57BL/6 mice differ in polyreactive IgA abundance, which impacts the generation of antigen-specific IgA and microbiota diversity. Immunity 43:527–540. doi:10.1016/j.immuni.2015.08.011. PubMed DOI

Damlund DS, Metzdorff SB, Hasselby JP, Wiese M, Lundsager M, Nielsen DS, Buschard KS, Hansen AK, Frøkiær H. 2016. Postnatal hematopoiesis and gut microbiota in NOD mice deviate from C57BL/6 mice. J Diabetes Res 2016:6321980. doi:10.1155/2016/6321980. PubMed DOI PMC

Vlaminck J, Cools P, Albonico M, Ame S, Ayana M, Bethony J, Cringoli G, Dana D, Keiser J, Maurelli MP, Montresor A, Mekonnen Z, Mirams G, Corrêa-Oliveira R, Prichard R, Rashwan N, Rinaldi L, Sayasone S, Thomas E, Verweij JJ, Vercruysse J, Levecke B. 2018. Comprehensive evaluation of stool-based diagnostic methods and benzimidazole resistance markers to assess drug efficacy and detect the emergence of anthelmintic resistance: a Starworms study protocol. PLoS Negl Trop Dis 12:e0006912. doi:10.1371/journal.pntd.0006912. PubMed DOI PMC

Rashwan N, Bourguinat C, Keller K, Gunawardena NK, de Silva N, Prichard R. 2016. Isothermal diagnostic assays for monitoring single nucleotide polymorphisms in Necator americanus associated with benzimidazole drug resistance. PLoS Negl Trop Dis 10:e0005113. doi:10.1371/journal.pntd.0005113. PubMed DOI PMC

Li J, Katiyar SK, Hamelin A, Visvesvara GS, Edlind TD. 1996. Tubulin genes from AIDS-associated microsporidia and implications for phylogeny and benzimidazole sensitivity. Mol Biochem Parasitol 78:289–295. doi:10.1016/s0166-6851(96)02628-x. PubMed DOI

Thomas JH, Neff NF, Botstein D. 1985. Isolation and characterization of mutations in the beta-tubulin gene of Saccharomyces cerevisiae. Genetics 111:715–734. PubMed PMC

Jung MK, Wilder IB, Oakley BR. 1992. Amino acid alterations in the benA (beta-tubulin) gene of Aspergillus nidulans that confer benomyl resistance. Cell Motil Cytoskeleton 22:170–174. doi:10.1002/cm.970220304. PubMed DOI

Katiyar SK, Gordon VR, McLaughlin GL, Edlind TD. 1994. Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrob Agents Chemother 38:2086–2090. doi:10.1128/aac.38.9.2086. PubMed DOI PMC

Kwa MS, Veenstra JG, Roos MH. 1994. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1. Mol Biochem Parasitol 63:299–303. doi:10.1016/0166-6851(94)90066-3. PubMed DOI

Davidse LC, Flach W. 1977. Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans. J Cell Biol 72:174–193. doi:10.1083/jcb.72.1.174. PubMed DOI PMC

Salát J, Braunfuchsová P, Kopecký J. 2001. Experimental infection of immunocompetent and immunodeficient mice with Encephalitozoon cuniculi. Folia Parasitol (Praha) 48:249–254. doi:10.14411/fp.2001.041. PubMed DOI

Valenčáková A, Halanová M. 2012. Immune response to Encephalitozoon infection review. Comp Immunol Microbiol Infect Dis 35:1–7. doi:10.1016/j.cimid.2011.11.004. PubMed DOI

GlaxoSmithKline. 2007. Albenza (albendazole) tablets prescribing information. GlaxoSmithKline, Research Triangle Park, NC.

Dayan AD. 2003. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop 86:141–159. doi:10.1016/s0001-706x(03)00031-7. PubMed DOI

Sak B, Jandová A, Doležal K, Kváč M, Květoňová D, Hlásková L, Rost M, Olšanský M, Nurcahyo W, Foitová I. 2017. Effects of selected Indonesian plant extracts on E. cuniculi infection. Exp Parasitol 181:94–101. doi:10.1016/j.exppara.2017.07.014. PubMed DOI

Didier ES, Stovall ME, Green LC, Brindley PJ, Sestak K, Didier PJ. 2004. Epidemiology of microsporidiosis: sources and modes of transmission. Vet Parasitol 126:145–166. doi:10.1016/j.vetpar.2004.09.006. PubMed DOI

Seddon J, Bhagani S. 2011. Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal. HIV AIDS (Auckl) 3:19–33. doi:10.2147/HIV.S9274. PubMed DOI PMC

Hofmannová L, Sak B, Jekl V, Mináriková A, Skorič M, Kváč M. 2014. Lethal Encephalitozoon cuniculi genotype III infection in Steppe lemmings (Lagurus lagurus). Vet Parasitol 205:357–360. doi:10.1016/j.vetpar.2014.07.008. PubMed DOI

De Bosschere H, Wang Z, Orlandi PA. 2007. First diagnosis of Encephalitozoon intestinalis and E. hellem in a European brown hare (Lepus europaeus) with kidney lesions. Zoonoses Public Health 54:131–134. doi:10.1111/j.1863-2378.2007.01034.x. PubMed DOI

Katzwinkel-Wladarsch S, Lieb M, Helse W, Löscher T, Rinder H. 1996. Direct amplification and species determination of microsporidian DNA from stool specimens. Trop Med Int Health 1:373–378. doi:10.1046/j.1365-3156.1996.d01-51.x. PubMed DOI

Wolk DM, Schneider SK, Wengenack NL, Sloan LM, Rosenblatt JE. 2002. Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens. J Clin Microbiol 40:3922–3928. doi:10.1128/jcm.40.11.3922-3928.2002. PubMed DOI PMC

Dai J, Wang P, Adusumilli S, Booth CJ, Narasimhan S, Anguita J, Fikrig E. 2009. Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent. Cell Host Microbe 6:482–492. doi:10.1016/j.chom.2009.10.006. PubMed DOI PMC

Microsporidia (Encephalitozoon cuniculi) in Patients with Degenerative Hip and Knee Disease, Czech Republic

Comparison of the Concentration of Encephalitozoon cuniculi Genotypes I and III in Inflammatory Foci Under Experimental Conditions

Sparse Evidence for Giardia intestinalis, Cryptosporidium spp. and Microsporidia Infections in Humans, Domesticated Animals and Wild Nonhuman Primates Sharing a Farm-Forest Mosaic Landscape in Western Uganda

Encephalitozoon cuniculi Genotype II Concentrates in Inflammation Foci